UCA1 and non-small cell lung carcinoma: Our clinical data demonstrated that UCA1 expression levels were significantly higher in EGFR-mutant NSCLC patients who developed acquired resistance to EGFR-TKIs compared with before treatment levels, suggesting that high expression of UCA1 may be a mechanism of resistance to EGFR-TKIs.